Both Intec Pharma Ltd. (NASDAQ:NTEC) and Evofem Biosciences Inc. (NASDAQ:EVFM) are Biotechnology companies, competing one another. We will contrast their dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation.
Valuation and Earnings
Table 1 showcases the top-line revenue, earnings per share and valuation of Intec Pharma Ltd. and Evofem Biosciences Inc.
Table 2 represents Intec Pharma Ltd. (NASDAQ:NTEC) and Evofem Biosciences Inc. (NASDAQ:EVFM)’s return on equity, net margins and return on assets.
Institutional and Insider Ownership
Roughly 39.64% of Intec Pharma Ltd. shares are held by institutional investors while 81.6% of Evofem Biosciences Inc. are owned by institutional investors. Insiders held roughly 11.81% of Intec Pharma Ltd.’s shares. Insiders Competitively, held 0.2% of Evofem Biosciences Inc. shares.
In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.